Needham & Company LLC Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $23.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price decreased by Needham & Company LLC from $25.00 to $23.00 in a research note issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s price target points to a potential upside of 34.11% from the company’s previous close.

Several other research analysts have also recently weighed in on XRAY. Wells Fargo & Company initiated coverage on DENTSPLY SIRONA in a research report on Friday, February 14th. They set an “equal weight” rating and a $20.00 price target for the company. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Evercore ISI reissued an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Tuesday, February 18th. Ten equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $24.33.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $17.15 on Friday. The firm has a market capitalization of $3.41 billion, a P/E ratio of -8.28, a PEG ratio of 1.80 and a beta of 0.96. The stock has a 50-day simple moving average of $18.90 and a two-hundred day simple moving average of $21.58. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a fifty-two week low of $17.09 and a fifty-two week high of $34.91.

Institutional Trading of DENTSPLY SIRONA

Several large investors have recently bought and sold shares of XRAY. Vanguard Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock valued at $275,218,000 after buying an additional 348,532 shares in the last quarter. Nuance Investments LLC increased its stake in shares of DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. boosted its position in shares of DENTSPLY SIRONA by 2.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after acquiring an additional 314,343 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.